Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2025-03-06 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
113年度毛利率
Regulatory Filings Classification · 90% confidence The document is very short (378 characters) and contains a brief financial summary table with annual revenue, cost, gross profit, and gross margin percentages for two years. There is no detailed financial statement, management discussion, or comprehensive report content. It appears to be a simple financial data update or summary rather than a full report. Given the brevity and nature of the content, it does not qualify as an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It also does not fit other specific categories like Audit Report or Management Report. The document resembles a brief financial fact summary or data snippet, but since it is very short and lacks detailed context, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2025-03-06 Chinese
113年度營益分析
Interim / Quarterly Report Classification · 95% confidence The document contains financial data segmented by fiscal periods such as first quarter, half-year, third quarter, and full year for multiple years (111年度, 112年度, 113年度). It includes detailed financial metrics like operating revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin. The presence of quarterly and half-year data with substantive financial figures indicates this is a comprehensive interim or quarterly financial report rather than a brief announcement or summary. The document length is relatively short (1038 characters), but the content is substantive financial data, not just a notice or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). FY 2024
2025-03-06 Chinese
113年第4季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity, including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and total equity for the current and previous fiscal years. The data is presented in a structured format with monetary units and accounting items, indicating it is a financial statement or part of a financial report. The document length is 4167 characters, which is relatively short but contains substantive financial data rather than just an announcement or certification. There is no indication that this is a summary or presentation, nor is it a voting result or management change announcement. The content aligns with a comprehensive financial report for a period shorter than a full fiscal year, likely an interim or quarterly report, as it shows period-to-period equity changes and earnings. Therefore, the document is best classified as an Interim / Quarterly Report (IR). FY 2024
2025-03-06 Chinese
113年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the fiscal year 113 Q4 (which corresponds to 2024 Q4 in the Taiwanese calendar). It includes comprehensive financial data such as net income before tax, depreciation, amortization, changes in assets and liabilities, cash flows from operating, investing, and financing activities, and cash balances at the beginning and end of the period. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2311 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). FY 2024
2025-03-06 Chinese
113年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial figures for the fiscal year 113 (2024) and the previous year 112 (2023). It includes revenue, costs, expenses, net income, and earnings per share data. The presence of actual financial data and detailed accounting items indicates this is a financial report rather than an announcement or summary. The document length is 2113 characters, which is relatively short but contains substantive financial data, so it is not merely a report publication announcement. The content corresponds to a quarterly or interim financial report, as it covers the 4th quarter of the fiscal year and provides detailed financial results. Therefore, the appropriate classification is Interim / Quarterly Report (IR). FY 2024
2025-03-06 Chinese
113年第4季資產負債表
Annual Report Classification · 85% confidence The document contains a consolidated balance sheet with detailed financial data for the fiscal year ending December 31, 2024 (民國113年第4季). It includes asset, liability, and equity breakdowns with monetary amounts and percentages. The presence of comprehensive financial statements for a specific fiscal period indicates this is a financial report rather than a brief announcement or certification. The document length is 2935 characters, which is relatively short but contains substantive financial data. Given the detailed financial data and the period covered (year-end), this aligns with an Annual Report (10-K) or a similar comprehensive yearly financial report. However, since the document is in Chinese and the fiscal year is indicated as the 4th quarter of 民國113 (2024), and it is a consolidated balance sheet, it is consistent with an Annual Report (10-K) type filing. There is no indication that this is merely an announcement or a certification, nor is it a quarterly or interim report. Therefore, the best classification is Annual Report (10-K). FY 2024
2025-03-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.